Open access
Open access
Powered by Google Translator Translator

European Medicines Agency finds AstraZeneca vaccine is safe and benefits outweigh the risks

19 Mar, 2021 | 08:37h | UTC

COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets – European Medicines Agency

Commentaries: Restoring confidence after the covid-19 Oxford/AstraZeneca vaccine pause will be an uphill battle – The BMJ Opinion AND European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events – Health Policy Watch AND Expert reaction to announcement from EMA on Oxford-AstraZeneca vaccine and blood clots – Science Media Centre AND European regulators say AstraZeneca vaccine safe, but can’t rule out rare events – CIDRAP AND AstraZeneca vaccine safe, but rare risk of blood clots not ruled out, EU regulator says – LiveScience AND European Medicines Agency Finds AstraZeneca Vaccine Safe And Effective – NPR

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.